.biofargo-table-wrapper {overflow-x: auto;margin: 20px 0;-webkit-overflow-scrolling: touch;}.biofargo-spec-table {width: 100%;border-collapse: collapse;border: 1px solid #dee2e6;min-width: 600px;background: #fff;}.biofargo-spec-table th,.biofargo-spec-table td {border: 1px solid #dee2e6;padding: 12px;vertical-align: middle;white-space: normal;word-break: break-word;}@media (max-width: 600px) {.biofargo-table-wrapper {border: 1px solid #eee;border-radius: 8px;padding: 6px;background: #fff;}.biofargo-spec-table {min-width: 720px;}} Description Monoclonal antibodies against carbohydrate antigen 125 (CA125) are the most commonly used serum biomarker for ovarian cancer. They are widely employed in the development of immunoassay kits for the early screening of ovarian cancer, monitoring response to therapy, and assessing the risk of postoperative recurrence. Specifications Product Details Species Mouse Specificity Specific for CA125 Subtype mIgG1 Expression Host Mammalian cell Concentration 4.1 mg/mL (from COA) Molecular Mass 150 kDa Formulation Purified, Liquid Purification >95% Buffer PBS, pH7.4 Storage For long term storage, the product should be stored at -20°C or lower. Validity 3 years Instructions for Use Use the product directly before use or dilute it with an appropriate sterile buffer if required. Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results. Do not mix with other similar products to avoid cross-reactivity and potential interference. Cautions • Research Use Only: This product is not suitable for clinical diagnostics or therapeutic applications. • Preservation: Handle according to instructions to preserve its activity and stability. • Support: Contact our technical support team if you encounter any issues or questions. Documents 📄 Download COA
Related